Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4076-36-2
2. 5-methyl-1h-tetrazole
3. 5-methyl Tetrazole
4. 5-methyl-2h-tetrazole
5. 5-methyl-1h-tertazole
6. Tetrazole, 5-methyl-
7. 1h-tetrazole, 5-methyl-
8. 2h-tetrazole, 5-methyl-
9. G22vbq3qpy
10. Nsc-11136
11. 51855-49-3
12. Methyltetrazole
13. Nsc11136
14. 5-methyl-2h-1,2,3,4-tetrazole
15. 5-methyl-1h-1,2,3,4-tetraazole
16. Mfcd00129971
17. 5-methyl-1h Tetrazole
18. 5-methyl-1h-1,2,3,4-tetrazole
19. Unii-g22vbq3qpy
20. 5-methyl-1h-tetraazole #
21. Chembl477368
22. M 5t
23. 5-methyl-1,2,3,4-tetrazole
24. 5-methyl-1h-tetrazole, 97%
25. Dtxsid0074710
26. Xzglncksnvgdnx-uhfffaoysa-
27. Act08262
28. Albb-013537
29. Bcp22228
30. Zinc5211973
31. 5-methyl-1h-1,2,3,4-tertazole
32. Nsc 11136
33. Stk523132
34. Akos000263048
35. Akos005174188
36. Gs-3021
37. Sy031544
38. Db-025317
39. Bb 0262337
40. Ft-0602357
41. A825278
42. J-517733
43. F0001-1152
44. Xjm
| Molecular Weight | 84.08 g/mol |
|---|---|
| Molecular Formula | C2H4N4 |
| XLogP3 | -0.1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 0 |
| Exact Mass | 84.043596145 g/mol |
| Monoisotopic Mass | 84.043596145 g/mol |
| Topological Polar Surface Area | 54.5 Ų |
| Heavy Atom Count | 6 |
| Formal Charge | 0 |
| Complexity | 44.8 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A 5-Methyltetrazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 5-Methyltetrazole, including repackagers and relabelers. The FDA regulates 5-Methyltetrazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 5-Methyltetrazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 5-Methyltetrazole supplier is an individual or a company that provides 5-Methyltetrazole active pharmaceutical ingredient (API) or 5-Methyltetrazole finished formulations upon request. The 5-Methyltetrazole suppliers may include 5-Methyltetrazole API manufacturers, exporters, distributors and traders.
5-Methyltetrazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 5-Methyltetrazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 5-Methyltetrazole GMP manufacturer or 5-Methyltetrazole GMP API supplier for your needs.
A 5-Methyltetrazole CoA (Certificate of Analysis) is a formal document that attests to 5-Methyltetrazole's compliance with 5-Methyltetrazole specifications and serves as a tool for batch-level quality control.
5-Methyltetrazole CoA mostly includes findings from lab analyses of a specific batch. For each 5-Methyltetrazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
5-Methyltetrazole may be tested according to a variety of international standards, such as European Pharmacopoeia (5-Methyltetrazole EP), 5-Methyltetrazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (5-Methyltetrazole USP).
LOOKING FOR A SUPPLIER?
